JPM vs NDMO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NDMO exhibits severe financial distress according to deterministic metrics, highlighted by a critical Piotroski F-Score of 1/9. The fund is trading at a massive premium to its growth-based intrinsic value of $1.75, with a current price of $10.36. A catastrophic payout ratio of 297.60% indicates that dividends are unsustainable and likely funded by return of capital or leverage. Combined with a 0/100 technical trend and zero profit margins, the data suggests a high-risk profile with significant downside potential.
Compare Another Pair
Related Comparisons
JPM vs NDMO: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Nuveen Dynamic Municipal Opportunities Fund (NDMO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.